Fig. 2
From: SLAMF1 expression in breast cancer cells delays tumor growth in vivo
SLAMF1 expression in breast cancer subtypes. (A) Individual tissue spots on a slide containing both normal breast tissue and six types of breast cancer were stained with an anti-SLAMF1 antibody, followed by an Alexa488 polyclonal antibody. Nuclei were counterstained with DAPI. SLAMF1 is shown in green, and nuclei are shown in blue. (B) Positive expression of SLAMF1 was counted and quantified in the six types of human breast cancers. (C) SLAMF1 expression in four different breast cancer subtypes—luminal A, luminal B, HER2 positive, and TNBC—was quantified by immunofluorescence positive score. The relationship between SLAMF1 expression and breast cancer grade (D), as well as patient age (E), was visualized. Statistical significance is indicated as * p < 0.05, ** p < 0.01, *** p < 0.001.
